by Trevor Coughlan | Apr 30, 2022 | Clinical Trials
Only 13% of all clinical trials will be successful at bringing a product or device to market. However, if monitoring improves, we have demonstrated that: your chance for success increases and 2) in the event your trial might not succeed, On-Time Trials (OTT) has the...
by Trevor Coughlan | Feb 14, 2022 | Clinical Research
The “Big Quit” (aka the Great Resignation) is everywhere and certainly impacting clinical trials. The impact was felt over the last few years with forced lockdowns yet, when you look at clinicaltrials.gov a record 37K new studies were added in 2021 alone. This brings...
